EA202193325A1 - COMPOSITIONS OF ANTIBODIES TO TNF FOR USE IN THE TREATMENT OF PSORIATIC ARTHRITIS - Google Patents

COMPOSITIONS OF ANTIBODIES TO TNF FOR USE IN THE TREATMENT OF PSORIATIC ARTHRITIS

Info

Publication number
EA202193325A1
EA202193325A1 EA202193325A EA202193325A EA202193325A1 EA 202193325 A1 EA202193325 A1 EA 202193325A1 EA 202193325 A EA202193325 A EA 202193325A EA 202193325 A EA202193325 A EA 202193325A EA 202193325 A1 EA202193325 A1 EA 202193325A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
compositions
psoriatic arthritis
tnf
antibodies
Prior art date
Application number
EA202193325A
Other languages
Russian (ru)
Inventor
Дайен Д. Харрисон
Элизабет С. Ся
Ли-Лянь Ким
Ким Хун Ло
Original Assignee
Янссен Байотек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Байотек, Инк. filed Critical Янссен Байотек, Инк.
Priority claimed from PCT/IB2020/054435 external-priority patent/WO2020245676A1/en
Publication of EA202193325A1 publication Critical patent/EA202193325A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к композициям и способам, в которых применяют антитела к ФНО или их антигенсвязывающие фрагменты в лечении активного псориатического артрита (PsA), например, при лечении с применением антител к ФНО, имеющих тяжелую цепь (HC), содержащую аминокислотную последовательность SEQ ID NO:36, и легкую цепь (LC), содержащую аминокислотную последовательность SEQ ID NO:37.The present invention relates to compositions and methods using anti-TNF antibodies or antigen-binding fragments thereof in the treatment of active psoriatic arthritis (PsA), for example, in treatment with heavy chain anti-TNF antibodies (HC) comprising the amino acid sequence of SEQ ID NO :36, and a light chain (LC) containing the amino acid sequence of SEQ ID NO:37.

EA202193325A 2019-10-23 2020-05-11 COMPOSITIONS OF ANTIBODIES TO TNF FOR USE IN THE TREATMENT OF PSORIATIC ARTHRITIS EA202193325A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962924895P 2019-10-23 2019-10-23
PCT/IB2020/054435 WO2020245676A1 (en) 2019-06-03 2020-05-11 Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis

Publications (1)

Publication Number Publication Date
EA202193325A1 true EA202193325A1 (en) 2022-03-16

Family

ID=81077523

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202193325A EA202193325A1 (en) 2019-10-23 2020-05-11 COMPOSITIONS OF ANTIBODIES TO TNF FOR USE IN THE TREATMENT OF PSORIATIC ARTHRITIS

Country Status (1)

Country Link
EA (1) EA202193325A1 (en)

Similar Documents

Publication Publication Date Title
RU2014108047A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR PREVENTION OF Pancreatic Cancer
PE20200294A1 (en) ANTIBODIES THAT SPECIFICALLY BIND PD-1 AND METHODS OF USE
PE20130817A1 (en) PEPTIDE ANTIBODIES BETA AMYLOID ANTI-N3PGLU AND USES THEREOF
RU2013118448A (en) MULTI-SPECIFIC BINDING ANTIGEN MOLECULE WHICH HAS AN ALTERNATIVE FUNCTION TO THE FUNCTION OF THE BLOOD COAGING FACTOR VIII
EA201190132A1 (en) HUMANIZED ANTIBODIES, CONNECTING CD19, AND THEIR APPLICATION
EA202092844A1 (en) ANTI-INTERLEUKIN-17A ANTIBODY, PHARMACEUTICAL COMPOSITION AND THEIR APPLICATION
PE20141151A1 (en) CD27L ANTIGEN BINDING PROTEINS
RU2008152769A (en) HUMANIZED ANTIBODY AGAINST HUMAN OSTEOPONTIN
AR109533A2 (en) ANTI-FRACTALKINA ANTIBODIES OR A FRAGMENT OF UNION TO THE FKN OF THIS, COMPOSITIONS THAT INCLUDE IT AND METHODS TO TREAT INFLAMMATORY DISORDERS
RU2017113732A (en) AN ANTIBODY THAT HAS THE ABILITY TO NEUTRALIZE AN ACTIVITY SUBSTANCE, AN ALTERNATIVE FUNCTION OF COLLECTION FACTOR VIII (FVIII)
PE20220708A1 (en) ANTI-CD73 ANTIBODIES
PE20240802A1 (en) MULTI-SPECIFIC ANTIBODIES WITH SPECIFICATION FOR IL-4R AND IL-31
EA202190335A1 (en) ANTIBODY COMPOSITIONS AGAINST FCRN AND METHODS OF THEIR APPLICATION
ZA202205288B (en) Humanized antibody and method for using the same
RU2004108115A (en) RECOMBINANT ANTIBODIES AND COMPOSITIONS, AND ALSO WAYS OF THEIR CREATION AND USE
MX2022003074A (en) Anti-cd371 antibodies and uses thereof.
RU2021128024A (en) METHODS FOR CULTIVATION OF CELLS
PE20231082A1 (en) IL-10 MUTEINS AND FUSION PROTEINS THEREOF CROSS REFERENCE TO RELATED APPLICATIONS
RU2380377C2 (en) Nogo-A-BINDING MOLECULES AND PHARMACEUTICAL APPLICATION THEREOF
MX2013011414A (en) Novel anti-human il-23 receptor antibody.
MX2022000988A (en) Anti-il13 antigen binding proteins.
RU2011104709A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CANCER
EA202192508A1 (en) METHODS FOR OBTAINING COMPOSITIONS OF ANTIBODIES TO TNF
EA202193325A1 (en) COMPOSITIONS OF ANTIBODIES TO TNF FOR USE IN THE TREATMENT OF PSORIATIC ARTHRITIS
MX2021004976A (en) Anti-human fn14 antibody.